Clinical and Translational Medicine, 2024 · DOI: 10.1002/ctm2.1661 · Published: April 2, 2024
Spinal cord injury (SCI)-induced neuroinflammation and oxidative stress (OS) are crucial events causing neurological dysfunction. Aconitate decarboxylase 1 (ACOD1) and its metabolite itaconate (Ita) inhibit inflammation and OS by promoting alkylation of Keap1 to induce Nrf2 expression; however, it is unclear whether there is another pathway regulating their effects in inflammation-activated microglia after SCI. Here, we identified an unreported ACOD1-p62-Nrf2-ACOD1 feedback loop exerting anti-inflammatory and anti-OS in inflammatory microglia, and demonstrated the neuroprotective role of ACOD1 after SCI, which was different from that of endogenous and exogenous Ita.
ACOD1 is a key early target regulating neuroinflammation and OS after SCI.
ACOD1 may positively regulate autophagy in a manner different from that of exogenous Ita.
Future studies are needed to explain the difference between endogenous ACOD1/Ita and exogenous Ita and its derivatives.